RemeCare “M1 approved” by mHealthBelgium

16 August 2019

RemeCare Oncology was one of the first four mHealth apps included in the validation pyramid of mHealthBelgium. This approval means that this health application RemeCare Oncology has taken a first step towards a potential reimbursement when using this mobile application to guide cancer patients with their medication intake and monitor possible side effects during their chemotherapy.

This first step means that the government acknowledges that Remedus does have a CE certificate for the software as a medical device and that Remedus complies with the applicable GDPR legislation. The decision on a final reimbursement will follow in a further phase as you can read here.

Share

Recent news

Read our latest news

An important milestone for Remedus

Global

14 October 2021

An important milestone for Remedus

Mediq and Remedus are joining forces to strengthen themselves in the field of home care, healthcare solutions and medical devices…

Read more
Covid-19 patients discharged early thanks to telemonitoring

Global, Innovation, Innovative Projects

21 June 2021

Covid-19 patients discharged early thanks to telemonitoring

RemeCare supports the hospitals OLV and A.S.Z. in Aalst to let corona patients go home early and to prevent extra…

Read more
Successful implementation of home hospitalisation: the preconditions

Global

29 April 2021

Successful implementation of home hospitalisation: the preconditions

On April 21st 2021, Kom Op Tegen Kanker, a Flemish NGO which pioneers in the fight against cancer, organised a…

Read more